|
1
|
Scanlan MJ, Simpson AJ and Old LJ: The
cancer/testis genes: Review, standardization, and commentary.
Cancer Immun. 4:12004.PubMed/NCBI
|
|
2
|
Fratta E, Coral S, Covre A, Parisi G,
Colizzi F, Danielli R, Nicolay HJ, Sigalotti L and Maio M: The
biology of cancer testis antigens: Putative function, regulation
and therapeutic potential. Mol Oncol. 5:164–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ
and Chen YT: Cancer/testis antigens: An expanding family of targets
for cancer immunotherapy. Immunol Rev. 188:22–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hofmann O, Caballero OL, Stevenson BJ,
Chen YT, Cohen T, Chua R, Maher CA, Panji S, Schaefer U, Kruger A,
et al: Genome-wide analysis of cancer/testis gene expression. Proc
Natl Acad Sci USA. 105:20422–20427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng YH, Wong EW and Cheng CY:
Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.
Spermatogenesis. 1:209–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kulkarni P, Shiraishi T, Rajagopalan K,
Kim R, Mooney SM and Getzenberg RH: Cancer/testis antigens and
urological malignancies. Nat Rev Urol. 9:386–396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Whitehurst AW: Cause and consequence of
cancer/testis antigen activation in cancer. Annu Rev Pharmacol
Toxicol. 54:251–272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SY, Obata Y, Yoshida M, Stockert E,
Williamson B, Jungbluth AA, Chen YT, Old LJ and Scanlan MJ:
Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA.
100:2651–2656. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thim L: Trefoil peptides: From structure
to function. Cell Mol Life Sci. 53:888–903. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sands BE and Podolsky DK: The trefoil
peptide family. Annu Rev Physiol. 58:253–273. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Braun BC, Ringleb J, Waurich R, Viertel D
and Jewgenow K: Functional role of feline zona pellucida protein 4
trefoil domain: A sperm receptor or structural component of the
domestic cat zona pellucida? Reprod Domest Anim. 44:(Suppl 2).
S234–S238. 2009. View Article : Google Scholar
|
|
13
|
Park JH, Song MH, Lee CH, Lee MK, Park YM,
Old L and Lee SY: Expression of the human cancer/testis antigen
NY-SAR-35 is activated by CpG island hypomethylation. Biotechnol
Lett. 33:1085–1091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davis GL, Dempster J, Meler JD, Orr DW,
Walberg MW, Brown B, Berger BD, O'Connor JK and Goldstein RM:
Hepatocellular carcinoma: Management of an increasingly common
problem. Proc (Bayl Univ Med Cent). 21:266–280. 2008.PubMed/NCBI
|
|
15
|
Yoon SK and Chun HG: Status of
hepatocellular carcinoma in South Korea. Chin Clin Oncol.
2:392013.PubMed/NCBI
|
|
16
|
Bae JM, Lee MS, Shin MH, Kim DH, Li ZM and
Ahn YO: Cigarette smoking and risk of lung cancer in Korean men:
The Seoul male cancer cohort study. J Korean Med Sci. 22:508–512.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG
and Lee JS: Cancer statistics in Korea: Incidence, mortality,
survival and prevalence in 2010. Cancer Res Treat. 45:1–14. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YT, Hsu M, Lee P, Shin SJ,
MhawechFauceglia P, Odunsi K, Altorki NK, Song CJ, Jin BQ, Simpson
AJ and Old LJ: Cancer/testis antigen CT45: Analysis of mRNA and
protein expression in human cancer. Int J Cancer. 124:2893–2898.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gure AO, Chua R, Williamson B, Gonen M,
Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ and
Altorki NK: Cancer-testis genes are coordinately expressed and are
markers of poor outcome in non-small cell lung cancer. Clin Cancer
Res. 11:8055–8062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng JR, Chen HS, Mou DC, Cao J, Cong X,
Qin LL, Wei L, Leng XS, Wang Y and Chen WF: Expression of
cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and
its correlation with clinical parameters. Cancer Lett. 219:223–232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakagawa K, Noguchi Y, Uenaka A, Sato S,
Okumura H, Tanaka M, Shimono M, Ali Eldib AM, Ono T, Ohara N, et
al: XAGE-1 expression in non-small cell lung cancer and antibody
response in patients. Clin Cancer Res. 11:5496–5503. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kurashige T, Noguchi Y, Saika T, Ono T,
Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T,
et al: Ny-ESO-1 expression and immunogenicity associated with
transitional cell carcinoma: Correlation with tumor grade. Cancer
Res. 61:4671–4674. 2001.PubMed/NCBI
|
|
23
|
Scanlan MJ, Altorki NK, Gure AO,
Williamson B, Jungbluth A, Chen YT and Old LJ: Expression of
cancer-testis antigens in lung cancer: Definition of bromodomain
testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett.
150:155–164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ayyoub M, Taub RN, Keohan ML, Hesdorffer
M, Metthez G, Memeo L, Mansukhani M, Hibshoosh H, Hesdorffer CS and
Valmori D: The frequent expression of cancer/testis antigens
provides opportunities for immunotherapeutic targeting of sarcoma.
Cancer Immun. 4:72004.PubMed/NCBI
|
|
25
|
Dobrynin P, Matyunina E, Malov SV and
Kozlov AP: The novelty of human cancer/testis antigen encoding
genes in evolution. Int J Genomics. 2013:1051082013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pandey A, Kurup A, Shrivastava A, Radhi S,
Nguyen DD, Arentz C, D'Chuna N, Hardwick F, D'Souza MJ, Jenkins M,
et al: Cancer testes antigens in breast cancer: Biological role,
regulation, and therapeutic applicability. Int Rev Immunol.
31:302–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shiraishi T, Terada N, Zeng Y, Suyama T,
Luo J, Trock B, Kulkarni P and Getzenberg RH: Cancer/testis
antigens as potential predictors of biochemical recurrence of
prostate cancer following radical prostatectomy. J Transl Med.
9:1532011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kelman Z: PCNA: Structure, functions and
interactions. Oncogene. 14:629–640. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gerdes J, Schwab U, Lemke H and Stein H:
Production of a mouse monoclonal antibody reactive with a human
nuclear antigen associated with cell proliferation. Int J Cancer.
31:13–20. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ihmann T, Liu J, Schwabe W, Häusler P,
Behnke D, Bruch HP, Broll R, Windhovel U and Duchrow M: High-level
mRNA quantification of proliferation marker pKi-67 is correlated
with favorable prognosis in colorectal carcinoma. J Cancer Res Clin
Oncol. 130:749–756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bologna-Molina R, MosquedaTaylor A,
MolinaFrechero N, MoriEstevez AD and Sánchez-Acuña G: Comparison of
the value of PCNA and Ki-67 as markers of cell proliferation in
ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 1:e174–e179.
2013. View Article : Google Scholar
|
|
32
|
Song MH, Kim YR, Lee JW, Lee CH and Lee
SY: Cancer/testis antigen NY-SAR-35 enhances cell proliferation,
migration and invasion. Int J Oncol. 48:569–576. 2016.PubMed/NCBI
|
